S&P 500
5,939.30
-0.5%
-$31.51
DJI
42,319.74
-0.3%
-$108.00
NASDAQ
19,298.45
-0.8%
-$162.04
Bitcoin
103,926.00
-1.7%
-1,846.59
AAPL
$200.39
-1.2%
-$2.43
AMZN
$207.76
+0.3%
+$0.53
GOOG
$169.74
+0.2%
+$0.35
META
$683.71
-0.6%
-$4.24
MSFT
$467.07
+0.7%
+$3.20
NVDA
$139.88
-1.4%
-$2.04
TSLA
$285.20
-14.1%
-$46.85
Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights
Jun 2, 2025
by Keith Speights
What Is Residual Income?
May 30, 2025
by Keith Speights
When Stocks Slide, These Are the Sectors That Do Best
May 28, 2025
by Keith Speights
1 Growth Stock Down 15% to Buy Right Now
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.